Cargando…

Increased Association of Pulmonary Thromboembolism and Tuberculosis during COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital

Pulmonary thromboembolism (PTE) has been associated with tuberculosis (TB), but the true incidence is unknown. The aim of our study was to retrospectively evaluate the PTE prevalence in TB patients hospitalized at the National Institute for Infectious Diseases L. Spallanzani during the January 2016–...

Descripción completa

Detalles Bibliográficos
Autores principales:	Di Bari, Virginia, Gualano, Gina, Musso, Maria, Libertone, Raffaella, Nisii, Carla, Ianniello, Stefania, Mosti, Silvia, Mastrobattista, Annelisa, Cerva, Carlotta, Bevilacqua, Nazario, Iacomi, Fabio, Mondi, Annalisa, Topino, Simone, Goletti, Delia, Girardi, Enrico, Palmieri, Fabrizio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944753/ https://www.ncbi.nlm.nih.gov/pubmed/35326861 http://dx.doi.org/10.3390/antibiotics11030398

Ejemplares similares

Increase in Tuberculosis Diagnostic Delay during First Wave of the COVID-19 Pandemic: Data from an Italian Infectious Disease Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2021)

Common and Rare Hematological Manifestations and Adverse Drug Events during Treatment of Active TB: A State of Art
por: Minardi, Maria Letizia, et al.
Publicado: (2021)

Concurrent cavitary pulmonary tuberculosis and COVID-19 pneumonia with in vitro immune cell anergy
por: Musso, Maria, et al.
Publicado: (2021)

Usefulness of bronchoalveolar lavage in the management of patients presenting with lung infiltrates and suspect COVID-19-associated pneumonia: A case report
por: Gualano, Gina, et al.
Publicado: (2020)

Putting in harm to cure: Drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis. Experience from a tertiary hospital in Italy
por: Gualano, Gina, et al.
Publicado: (2019)

Hepatitis C virus infection: a challenge in the complex management of two cases of multidrug-resistant tuberculosis
por: Musso, Maria, et al.
Publicado: (2019)

Benefits of Steroid Therapy in COVID-19 Patients with Different PaO(2)/FiO(2) Ratio at Admission
por: Vita, Serena, et al.
Publicado: (2021)

Active Pulmonary Tuberculosis in Elderly Patients: A 2016–2019 Retrospective Analysis from an Italian Referral Hospital
por: Di Gennaro, Francesco, et al.
Publicado: (2020)

Characterization of the immune impairment of patients with tuberculosis and COVID-19 coinfection
por: Najafi-Fard, Saeid, et al.
Publicado: (2023)

Recovery from Triple Infection with SARS-CoV-2, RSV and Influenza virus: A case report
por: Guido, Giacomo, et al.
Publicado: (2023)

Detection of Pulmonary tuberculosis: comparing MR imaging with HRCT
por: Busi Rizzi, Elisa, et al.
Publicado: (2011)

Spike is the most recognized antigen in the whole-blood platform in both acute and convalescent COVID-19 patients
por: Aiello, Alessandra, et al.
Publicado: (2021)

PMN-MDSC Frequency Discriminates Active Versus Latent Tuberculosis and Could Play a Role in Counteracting the Immune-Mediated Lung Damage in Active Disease
por: Grassi, Germana, et al.
Publicado: (2021)

Isoniazid prophylaxis differently modulates T-cell responses to RD1-epitopes in contacts recently exposed to Mycobacterium tuberculosis: a pilot study
por: Goletti, Delia, et al.
Publicado: (2007)

Exploratory analysis to identify the best antigen and the best immune biomarkers to study SARS-CoV-2 infection
por: Petruccioli, Elisa, et al.
Publicado: (2021)

A whole blood test to measure SARS-CoV-2-specific response in COVID-19 patients
por: Petrone, Linda, et al.
Publicado: (2021)

Coinfection of tuberculosis and COVID-19 limits the ability to in vitro respond to SARS-CoV-2
por: Petrone, Linda, et al.
Publicado: (2021)

Timing and Outcomes of Noninvasive Ventilation in 307 ARDS COVID-19 Patients: An Observational Study in an Italian Third Level COVID-19 Hospital
por: Tetaj, Nardi, et al.
Publicado: (2022)

Down Syndrome patients with COVID-19 pneumonia: A high-risk category for unfavourable outcome
por: Vita, Serena, et al.
Publicado: (2021)

Improved detection of human influenza A and B viruses in respiratory tract specimens by hemi-nested PCR
por: Minosse, Claudia, et al.
Publicado: (2007)

Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic wave
por: Aiello, Alessandra, et al.
Publicado: (2022)

Antibiotics and Infectious Respiratory Diseases
por: Di Gennaro, Francesco, et al.
Publicado: (2022)

Multidrug-Resistant Tuberculosis In A Referral Center In Rome: 2011– 2016
por: Cannas, A, et al.
Publicado: (2019)

Tuberculosis case finding based on symptom screening among immigrants, refugees and asylum seekers in Rome
por: Sañé Schepisi, Monica, et al.
Publicado: (2013)

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use
por: Gualano, Gina, et al.
Publicado: (2016)

Salmonella Hessarek Gastroenteritis with Bacteremia: A Case Report and Literature Review
por: Chinello, Pierangelo, et al.
Publicado: (2020)

Relationship between body mass index and bone mineral density in HIV-infected patients referred for DXA
por: Pinnetti, Carmela, et al.
Publicado: (2014)

In-vitro evaluation of the immunomodulatory effects of Baricitinib: Implication for COVID-19 therapy
por: Petrone, Linda, et al.
Publicado: (2021)

Incidence of Pneumothorax and Pneumomediastinum in 497 COVID-19 Patients with Moderate–Severe ARDS over a Year of the Pandemic: An Observational Study in an Italian Third Level COVID-19 Hospital
por: Tetaj, Nardi, et al.
Publicado: (2021)

Accuracy of QuantiFERON SARS-CoV-2 research use only assay and characterization of the CD4(+) and CD8(+) T cell-SARS-CoV-2 response: comparison with a homemade interferon-γ release assay
por: Aiello, Alessandra, et al.
Publicado: (2022)

Risk of Tuberculosis Reactivation in Patients with Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Receiving Non-Anti-TNF-Targeted Biologics
por: Cantini, Fabrizio, et al.
Publicado: (2017)

Sarilumab plus standard of care vs standard of care for the treatment of severe COVID-19: a phase 3, randomized, open-labeled, multi-center study (ESCAPE study)
por: Mastrorosa, Ilaria, et al.
Publicado: (2023)

Evaluation of the immunomodulatory effects of interleukin-10 on peripheral blood immune cells of COVID-19 patients: Implication for COVID-19 therapy
por: Najafi-Fard, Saeid, et al.
Publicado: (2022)

Response to M. tuberculosis selected RD1 peptides in Ugandan HIV-infected patients with smear positive pulmonary tuberculosis: a pilot study
por: Goletti, Delia, et al.
Publicado: (2008)

Acute HIV infection (AHI) in a specialized clinical setting: case-finding, description of virological, epidemiological and clinical characteristics
por: Ammassari, Adriana, et al.
Publicado: (2014)

A Systematic Review of the Guidelines on Venous Thromboembolism Prophylaxis in Gynecologic Oncology
por: Romano, Federico, et al.
Publicado: (2022)

Prophylactic heparin and risk of orotracheal intubation or death in patients with mild or moderate COVID-19 pneumonia
por: Vergori, Alessandra, et al.
Publicado: (2021)

Baricitinib Therapy in Covid-19 Pneumonia — An Unmet Need Fulfilled
por: Goletti, Delia, et al.
Publicado: (2021)

Serological evaluation for Chagas disease in migrants from Latin American countries resident in Rome, Italy
por: Pane, Stefania, et al.
Publicado: (2018)

IP-10 detection in urine is associated with lung diseases
por: Cannas, Angela, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6806h6k2g0vki0pklrkoit80tf